Governance Iqvia Holdings Inc.

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 21:00:03 17/06/2026 BST			After hours 01:00:00
170.67 ^USD	-4.74%		174.54	+2.27%

06-17	IQVIA Shares Fall After Morgan Stanley Downgrade	MT
06-17	Morgan Stanley Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts Price Target to $200 From $225	MT

Executive Committee: Iqvia Holdings Inc.

Manager

Positions heldSince

Ari Bousbib

64 year

Chief Executive Officer	02/10/2016
President	02/10/2016

Jeffrey Spaeder

Chief Tech/Sci/R&D Officer

Christina Mack

Chief Tech/Sci/R&D Officer

31/12/2025

Susan Hill

Chief Tech/Sci/R&D Officer

Bernd Haas

50 year

Chief Tech/Sci/R&D Officer

30/11/2025

Rob Kotchie

Chief Tech/Sci/R&D Officer

31/12/2025

Michael Fedock

51 year

Director of Finance/CFO

27/02/2026

Kerri Joseph

Investor Relations Contact	31/01/2024
Treasurer	31/01/2024

Keriann Cherofsky

42 year

Comptroller/Controller/Auditor

31/07/2022

James Berkshire

53 year

Chief Operating Officer

30/06/2017

Eric Sherbet

61 year

General Counsel	28/02/2018
Corporate Secretary	28/02/2018

Natalia Kotchie

Chief Tech/Sci/R&D Officer

31/12/2025

W. Richard Staub

63 year

Chief Tech/Sci/R&D Officer

24/09/2023

Trudy Stein

Human Resources Officer

02/10/2016

Composition of the Board of Directors: Iqvia Holdings Inc.

Director

CommitteesSince

Ari Bousbib

64 year

Audit Committee	14/06/2009
Finance Committee Chair	10/04/2013

John Danhakl

69 year

Compensation Committee Chair	31/12/1994
Nominating Committee Chair	31/12/1994
Compensation Committee
Governance Committee	31/05/2015
Nominating Committee	31/05/2015

Carol Burt

68 year

Audit Committee	30/09/2019
Governance Committee	31/10/2013
Nominating Committee Chair	31/10/2013
Audit Committee Chair
Compensation Committee Chair

Sheila Stamps

68 year

Compensation Committee	14/12/2021
Governance Committee	14/12/2021
Nominating Committee	14/12/2021
Audit Committee	25/01/2022

John Leonard

68 year

Audit Committee	30/09/2016
Compensation Committee	04/02/2015
Governance Committee	30/09/2016
Nominating Committee	30/09/2016

Colleen Goggins

70 year

Audit Committee	26/07/2017
Governance Committee Chair	26/07/2017
Nominating Committee Chair	26/07/2017

Jim Fasano

56 year

Compensation Committee	02/10/2016
Audit Committee Chair	02/10/2016

Leslie Morris

55 year

Governance Committee	23/01/2022
Nominating Committee	23/01/2022

William Kaelin

68 year

Governance Committee	04/11/2025
Nominating Committee	04/11/2025

Latest Appointments: Iqvia Holdings Inc.

03-30	Cipla Limited Announces Appointment of Senior Management Personnel of the Company Effective 1 April, 2026	CI
03-23	Royalty Pharma plc Appoints Lucas Glass as Head of Artificial Intelligence, Effective April 2026	CI
03-20	Aquestive Therapeutics, Inc. Announces Executive Changes, Effective April 2, 2026	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-17	Fortrea Announces Executive Changes	CI
01-08	Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026	CI
12-17	Bavarian Nordic as Appoints Anne Louise Eberhard as New Chair of the Board of Directors	CI

More news

Former Officers and Directors: Iqvia Holdings Inc.

Insider

Positions held

SinceUntil

Todd Sisitsky

Director/Board Member	31/12/2015	22/04/2026
Independent Dir/Board Member	31/12/2015	22/04/2026

Ronald Bruehlman

Director of Finance/CFO

31/07/2020

27/02/2026

Gregg Dearhammer

Corporate Officer/Principal

31/10/2017

30/07/2025

John Connaughton

Director/Board Member	31/12/2007	23/04/2025
Independent Dir/Board Member	31/12/2007	23/04/2025

Sanjay Chikarmane

Corporate Officer/Principal

31/07/2021

27/02/2025

Kevin Knightly

Corporate Officer/Principal

14/05/2024

Costa Panagos

Chief Tech/Sci/R&D Officer

24/09/2023

Ronald Rittenmeyer

Director/Board Member	02/10/2016	01/10/2022
Independent Dir/Board Member	02/10/2016	01/10/2022

Tor Constantino

Public Communications Contact

31/07/2013

31/07/2022

Emmanuel N. Korakis

Comptroller/Controller/Auditor	31/10/2018	30/07/2022
Treasurer	-	30/07/2022

Jean Roberson

Director of Finance/CFO

30/06/2020

31/05/2022

Drayton Virkler

Corporate Officer/Principal

30/09/2011

31/08/2021

Nick Childs

Investor Relations Contact	31/03/2021	-
Public Communications Contact	31/03/2021	-
Treasurer	-	-

Jennifer Halchak

Investor Relations Contact

31/12/2018

31/12/2020

Michael McDonnell

Director of Finance/CFO

30/11/2015

30/07/2020

Michael J. Evanisko

Director/Board Member	30/04/2010	05/04/2020
Independent Dir/Board Member	30/04/2010	05/04/2020

Jonathan Coslet

Director/Board Member	31/12/2002	31/12/2019
Independent Dir/Board Member	31/12/2002	31/12/2019

Manav Dagar

Private Equity Investor

31/12/2018

30/10/2019

Donna Kralowetz

Director of Finance/CFO

30/04/2017

30/05/2019

Jack Greenberg

Director/Board Member	31/12/2003	31/03/2019
Independent Dir/Board Member	31/12/2003	31/03/2019

Charles Edward Williams

Comptroller/Controller/Auditor

31/10/2018

James Hanson

Corporate Officer/Principal

31/10/2017

31/05/2018

Benjamin Hughes

Corporate Officer/Principal

31/12/2013

28/02/2018

Richie Etwaru

Corporate Officer/Principal

31/03/2015

28/02/2018

James Erlinger

General Counsel	02/10/2016	27/02/2018
Corporate Secretary	02/10/2016	27/02/2018

Karl Guenault

Chief Tech/Sci/R&D Officer

31/10/2017

Terry Murdock

Corporate Officer/Principal

31/08/2014

30/06/2017

Michael Stibilj

Corporate Officer/Principal

31/12/2014

31/05/2017

Tal Rosenberg

Corporate Officer/Principal

30/09/2016

Marla Kessler

Public Communications Contact	30/09/2016	-
Sales & Marketing	30/09/2016	-

Kevin Gordon

Chief Operating Officer

30/09/2015

30/09/2016

Darcie Peck

Investor Relations Contact	30/04/2002	31/10/2009
Corporate Officer/Principal	31/10/2009	31/01/2016

Lisa van Capelle

Human Resources Officer

31/12/2003

31/12/2015

Melissa Beelen

Corporate Officer/Principal

31/07/2010

31/10/2015

Fred Cohen

Director/Board Member

31/12/2006

31/10/2015

Michael Ackermann

Private Equity Investor

30/04/2009

31/10/2013

Christopher Katz

Consultant / Advisor

31/05/2010

30/07/2012

Thomas Pike

Director/Board Member	31/12/2011	-
Corporate Officer/Principal	31/12/2011	-

Daniel Barton

Corporate Officer/Principal

31/10/2011

Qiao Ling Lu

Corporate Officer/Principal

31/03/2006

31/07/2010

John Hernandez

Corporate Officer/Principal

31/12/1999

31/12/2000

David Hood

Corporate Officer/Principal

31/12/1992

31/12/1999

Cynthia L. Verst

Corporate Officer/Principal

Paul Kirchgraber

Chief Tech/Sci/R&D Officer

Caroline Ruiz

Corporate Officer/Principal

Patrick Daly

Corporate Officer/Principal

Phil Bridges

Public Communications Contact

Melissa Schwarting

Public Communications Contact

Edward Spaniel

General Counsel

Gary Koch

Founder

Andrei Stoica

Corporate Officer/Principal

Christopher Gordon

Director/Board Member

Margaret Keegan

Chief Tech/Sci/R&D Officer

Anand Kumaresh Tharmaratnam

President

Andrew Markwick

Investor Relations Contact	-	-
Treasurer	-	-

Ibraheem Mahmood

Corporate Officer/Principal

Jon Resnick

Corporate Officer/Principal

Dennis Gillings

Founder

31/12/1981

Age distribution of managers

Parity Men Women

Male	18
Female	8

Of which Executive Committee

Male	10
Female	4

Of which Directors

Male	5
Female	4

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (40.6%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.9%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.5%), Europe and Africa (31.8%) and Asia/Pacific (20.7%).

Employees

93,000

Sector

Biotechnology & Medical Research

More about the company